Donidalorsen - Hereditary angioedema

You are here : Home > Formulary Search > Donidalorsen - Hereditary angioedema

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Pre-filled pen

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

NHSE

Restrictions / Comments :

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Donidalorsen

Indication :

Hereditary angioedema

Group Name :

Keywords :

Brand Names Include :

Dawnzera

Important Information :

For preventing recurrent attacks of hereditary angioedema in people 12 years and over in line with NICE TA 1183

Overview | Donidalorsen for preventing recurrent attacks of hereditary angioedema in people 12 years and over | Guidance | NICE

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Committee Recommendations (0)

No records returned.

Other Indications

Below are listed other indications that Donidalorsen is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hereditary angioedema.